1. Catalogs
  2. SHL Telemedicine
  3. Half Year Report 2016

Half Year Report 2016

Half Year Report 2016
1 / 16 PagesView full catalog

Half Year Report 2016

Product catalog summary
Overview: The first half of 2016 was a transitional period for SHL Telemedicine Ltd., marked by leadership changes and discussions with Shanghai Jiuchuan Investment. Financial results showed adjusted revenues of USD 18.3 million, a 2.7% decrease from the previous year, and an adjusted EBITDA of USD 0.8 million, down from USD 1.3 million in 2015. The adjusted net loss was USD 2.5 million compared to USD 1.8 million in 2015.
Regional Performance: In Germany, adjusted revenues rose by 6.4% to USD 8.3 million due to the acquisition of GPH. In Israel, revenues fell by 9.2% to USD 9.9 million, mainly due to decreased revenues from institutional clients. A new General Manager, Eran Kristal, was appointed to boost growth and profitability in Israel.
Strategic Focus: SHL aims to enhance profitability by streamlining operations and cutting costs, with initial positive impacts observed in Q2 2016. The company plans to expand its platforms in Germany and Israel and explore new territories for its smartheart™ platform.
Investment and Trust: Mrs. Cai Mengke, co-founder of Zhuhai Hokai Medical Instruments, invested in SHL, reflecting confidence in SHL's products and potential in the Chinese market.
Financial Adjustments: Adjusted financial figures provide better insight into operational performance, with adjusted revenues for H1 2016 at USD 18.3 million and a net loss of USD 2.5 million. The report includes reconciliations for comparability.
Financial Statements: The report includes condensed consolidated balance sheets, statements of comprehensive income, changes in equity, and cash flows. As of June 30, 2016, total assets were USD 72 million, liabilities USD 32.6 million, and equity USD 39.4 million.
Conclusion: The interim financial statements review was conducted according to international standards, with no significant issues identified. The report was approved on September 15, 2016, by the Chairman and CEO.
Condensed Consolidated Statements of Cash Flows: The document summarizes cash flows for SHL Telemedicine Ltd. for the year ended December 31, 2015, and the six months ended June 30, 2016. Key figures include a net cash increase of $195,000 for the six months ended June 30, 2016, and cash equivalents totaling $4,200,000 at the end of the period.
Notes to Interim Consolidated Financial Statements:
  • General: The financial statements are prepared in a condensed format and should be read alongside the annual financial statements of December 31, 2015.
  • Significant Accounting Policies: The interim statements follow the same accounting policies as the annual statements, in accordance with IAS 34.
  • Transactions and Material Events: Notable events include the acquisition of GPH, changes in executive leadership, and adjustments to performance-based revenue estimates.
Financial Instruments: The document details the measurement hierarchy of financial assets, with available-for-sale investments and financial assets at fair value through profit or loss totaling $4,554,000 as of June 30, 2016.
Segment Information: SHL operates in three geographic segments: Israel, Europe, and the Rest of the World. For the six months ended June 30, 2016, total revenues were $17,342,000, with a segment loss of $2,914,000.
Subsequent Events: Key events include the appointment of a new CFO and a significant share purchase by a Chinese investor.
Capital Structure: The company has 10,489,333 registered shares, with significant shareholders holding more than 3% of voting rights. The market capitalization as of June 30, 2016, was CHF 74.5 million.
Investor Relations: Contact information for SHL Telemedicine Ltd. is provided, including details for the CEO and CFO.
See more

Catalog excerpts

Half Year Report 2016-1

Half Year Report 2016

 Open the catalog to page 1
Half Year Report 2016-2

SHL Telemedicine Ltd. 1 January - 30 June on all fronts and reducing our cost base. The initial impact was already seen in the second Shanghai Jiuchuan Investment (Group) Co., Ltd. last quarter of 2016 and led to a reduction in the free year, responsibility both in the Board of Directors cash burn rate. The reduction in costs should and the leadership team was put into new hands. continue to further materialize during the course of the year with the full impact seen in 2017. Financial results in the first half-year are to be a seen on this backdrop. Adjusted revenues  were In terms of defining...

 Open the catalog to page 2
Half Year Report 2016-3

SHL Telemedicine Ltd. 1 January - 30 June Half-Year Report 2016 Financial Highlights a. Adjusted Financial Information in USD million (except per share amounts) • Israel 9.9 10.9 (9.2)% • Other 0.1 0.1 b Adjusted LBIT  (1.8) (1.2) n.a b Adjusted EBITDA  0.8 Adjusted LPS (0.24) (0.17) n.a Adjusted free cash flow1,2 (1.3) (2.2) n.a 3 b. Reconciliation to Adjusted Financial Information EBIT/ EBITDA/ Net income Revenues (LBIT) (LBITDA) (loss) EBIT/ EBITDA/ Net income Revenues (LBIT) (LBITDA) (loss) with past customer Change in revenue estimate Change in revenue estimate Amortization of acquisition...

 Open the catalog to page 3
Half Year Report 2016-4

| Report on Review of Interim Condensed Consolidated Financial Statements | Condensed Consolidated Balance Sheets | Condensed Consolidated Statements of Comprehensive Income (Loss) | Condensed Consolidated Statements of Changes in Equity | Condensed Consolidated Statements of Cash Flows | Notes to Interim Condensed Consolidated Financial Statements Financial Statements

 Open the catalog to page 4
Half Year Report 2016-5

The Shareholders and Board of Directors SHL Telemedicine Ltd. Re: Report on review of interim condensed consolidated financial statements We have reviewed the accompanying interim procedures. A review is substantially less in condensed consolidated balance sheet of SHL scope than an audit conducted in accordance with International Standards on Auditing and subsidiaries as of June 30, 2016, and the related interim condensed consolidated statements of assurance that we would become aware of all comprehensive income, changes in equity and cash significant matters that might be identified in an flows...

 Open the catalog to page 5
Half Year Report 2016-6

CONDENSED CONSOLIDATED BALANCE SHEETS U.S. dollars in thousands Unaudited Audited ASSETS CURRENT ASSETS: Cash and cash equivalents Short-term investments PROPERTY AND EQUIPMENT: Cost Less - accumulated depreciation (54,423) (51,573) (51,915) Total assets The accompanying notes are an integral part of the interim condensed consolidated financial statements. Financial Statements

 Open the catalog to page 6
Half Year Report 2016-7

CONDENSED CONSOLIDATED BALANCE SHEETS U.S. dollars in thousands Unaudited Audited LIABILITIES AND EQUITY CURRENT LIABILITIES: Credit from banks and current maturities Deferred revenues 2,035 1,870 1,828 Trade payables Other accounts payable 5,466 5,971 6,840 NON-CURRENT LIABILITIES: Long-term loans Deferred revenues Deferred taxes Employee benefit liabilities Total liabilities EQUITY: Issued capital Additional paid-in capital 95,712 95,229 95,380 Treasury shares (2,440) (2,440) (2,440) Foreign currency translation reserve (3,262) (2,016) (4,086) Capital reserve for available-for sale investments...

 Open the catalog to page 7
Half Year Report 2016-8

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME U.S. dollars in thousands (except per share amounts) Year ended Six months ended June 30, Unaudited Audited Revenues 18,290 21,085 40,673 Change in revenues estimate (948) - (6,092) Total revenues Depreciation and amortization Cost of revenues Research and development costs 1,491 1,120 2,690 Selling and marketing expenses 4,577 5,405 10,794 General and administrative expenses 4,652 3,402 8,052 522 7,876 Other expenses - Operating income (loss) (3,749) Financial income 134 561 878 Financial expenses (416) (673) (1,261) Income (loss) before...

 Open the catalog to page 8
Half Year Report 2016-9

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY U.S. dollars in thousands Capital reserve for available-for-sale Foreign investments and Additional currency remeasurement Issued paid-in Treasury translation gains on defined capital capital shares reserve benefit plans** Balance as of January 1, 2015 (audited) Share-based payments Total other comprehensive loss Balance as of December 31, 2015 (audited) Accumulated deficit Share-based payments Total other comprehensive income Balance as of June 30, 2016 (unaudited) * Represents an amount lower than $ 1. ** As of June 30, 2016 the capital...

 Open the catalog to page 9
Half Year Report 2016-10

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Year ended Six months ended June 30, December 31, Unaudited Audited Cash flows from operating activities: Adjustments required to reconcile net income (loss) to net cash provided by (used in) operating activities: Income and expenses not involving operating cash flows: Capital gain from sale of property and equipment (6) (26) Impairment of property, plant and equipment - 877 Impairment of intangible assets - 1,800 Change in employee benefit liabilities, net 66 77 20 Cost of share-based payments 332 210 361 Changes in operating assets and liabilities:...

 Open the catalog to page 10
Half Year Report 2016-11

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Six months ended June 30, Year ended Cash flows from investing activities: Purchase of property and equipment Investment in intangible assets Long-term deposit Proceeds from sale of property and equipment Purchase of financial assets Proceeds from sale of financial assets Net cash provided by (used in) investing activities (897) 1,754 532 Cash flows from financing activities: Proceeds from exercise of options 9 8 Short term bank credit, net Proceeds from long-term loans Payment of long-term loans Net cash provided by (used in) financing activities...

 Open the catalog to page 11
Half Year Report 2016-12

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS U.S. dollars in thousands Six months ended June 30, Year ended December 31, Unaudited Audited (a) Acquisition of GPH: Working capital (excluding cash) Intangible assets Deferred taxes (b) Non-cash transactions: Purchase of property and equipment on credit The accompanying notes are an integral part of the interim condensed consolidated financial statements. Financial Statements

 Open the catalog to page 12

All SHL Telemedicine catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.